NASDAQ
Merus Announces $55.8 Million Private Placement Offering of Common Stock
UTRECHT, The Netherlands, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology ...
Environmental Testing Markets, 2016-2024 – Global Strategic Business Report 2018
Dublin, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The "Environmental Testing - Global Strategic Business ...
Environmental Testing Markets, 2016-2024 – Global Strategic Business Report 2018
Dublin, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The "Environmental Testing - Global Strategic Business ...
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis ...
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis ...
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis ...
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis ...
Oncobiologics Receives Positive Nasdaq Listing Determination
CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced ...
Oncobiologics Receives Positive Nasdaq Listing Determination
CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced ...
Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 27
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...
Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 27
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...
Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...
Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...